Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6667050 | APIL | Chewable oral contraceptive |
Apr, 2019
(5 years ago) |
Market Authorisation Date: 14 November, 2003
Treatment: Prevention of pregnancy
Dosage: TABLET;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5552394 | TEVA BRANDED PHARM | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
Jul, 2014
(9 years ago) | |
US6667050 | TEVA BRANDED PHARM | Chewable oral contraceptive |
Apr, 2019
(5 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product(NP) | Dec 22, 2013 |
Market Authorisation Date: 22 December, 2010
Treatment: Prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception
Dosage: TABLET, CHEWABLE;ORAL